Search results
globenewswire.com
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases.
www.marketbeat.com/stocks/NASDAQ/XBIT/
People also ask
What does XBiotech do?
What makes XBiotech unique in its field?
Where is XBiotech's headquarters located?
Are XBiotech antibodies humanized?
XBiotech’s technologies provide us with the unique ability to develop drug candidates for viral or bacterial infectious diseases. Our core discovery technology enables the rapid development of antibody therapies directly from human blood samples that can be used to neutralize infectious disease.
- Clinical
xbiotech in-house clinical department XBiotech clinical...
- Manufacturing
XBiotech has a fully integrated research and manufacturing...
- Leadership
Leadership - About XBiotech — XBiotech
- Clinical
Feb 25, 2024 · A look at the shareholders of XBiotech Inc. (NASDAQ:XBIT) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are retail investors with 44% ownership.
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a...
Jul 22, 2020 · XBiotech currently is advancing a pipeline of therapies by harnessing naturally occurring antibodies from patients with immunity to certain diseases. Utilizing natural human immunity as a source of new medicines offers the potential to redefine the standards of care for a wide range of diseases.
Aug 8, 2023 · XBiotech discovered genetic engineering tools that enabled identification of rare antibodies present in human donor blood, and has built a pipeline of antibody therapies, including a candidate therapy that could revolutionize arthritis treatment.
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases.
Apr 15, 2015 · XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases.
